Gait adaptability in people with mild multiple sclerosis
Official title: Multidimensional Assessment of Gait Adaptability in Persons Multiple Sclerosis With no to Mild Disability
Run by Hasselt University · NCT07580820 · Data updated 2026-11-12
This project tests how well adults with mild multiple sclerosis can adapt their walking to changing challenges compared with healthy adults using walking tasks, wearable sensors, and questionnaires.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Hasselt University Academic / other |
| Locations | 1 site (Diepenbeek) |
| Status | Recruiting |
| Started | December 5, 2025 |
| Main results expected | September 1, 2026 |
| Study ends | December 20, 2026 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT07580820 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a confirmed diagnosis of MS, relapse-free for at least 30 days, and an EDSS score between 0 and 3.5 are ideal candidates.
✕Probably not a fit
People with more advanced disability (EDSS >3.5), other neurological/orthopedic/visual conditions that affect gait, or cognitive decline that prevents completing tests are unlikely to benefit from these measurements.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will recruit 16 adults with mild MS (EDSS 0–3.5) and 16 age- and sex-matched healthy controls for a single in-person testing session at Hasselt University's REVAL center. Participants will complete timed motor tests (e.g., Timed 25‑Foot Walk, Six-Spot Step Test, 6‑Minute Walk), balance assessments (Mini-BESTest), cognitive tests (SDMT, BVMT-R), and self-report questionnaires on fatigue, walking, and balance confidence. Proactive gait adaptability will be probed using an overground Walking Adaptability Ladder Test with progressively smaller stepping targets, while wearable movement sensors record kinematics; reactive responses will be examined with appropriate perturbation and obstacle tasks. Data will be compared between groups to characterize adaptability deficits and their relationships with fatigue, cognition, and fall-related measures.
Why it matters
Potential benefit: If successful, this work could help clinicians detect subtle walking and balance problems earlier so rehabilitation and fall-prevention strategies can be better targeted.
How similar studies have gone: Previous studies using sensor-based gait measures and adaptability tasks in MS and older adults have shown promise at revealing subtle deficits, though these methods are not yet routine in clinical care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18-65 years, * confirmed diagnosis of definite MS, * relapse free at least 30 days, * Expanded Disability Status Scale (EDSS) score between 0 and 3.5 Exclusion Criteria: * Diagnosed with neurological disease other than MS * cognitive decline that renders the patient incapable of performing tests and questionnaires. * Other neurological, orthopedic, or visual impairments affecting gait
Where it's running
-
REVAL Rehabilitation Research Center, University of Hasselt
Diepenbeek, Belgium Recruiting
Study contacts
- Study coordinator: Zuhal Abasiyanik, PhD
- Email: zuhal.abasiyanik@uhasselt.be
- Phone: +32(0)11 26 93 06
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.